Wisconsin Legislature: Drugs

Drug products prescribed to counteract anaphylaxis: therapeutic interchange by pharmacist allowed - AB849

Drug products prescribed to counteract anaphylaxis: therapeutic interchange by pharmacist allowed - SB783

Duty of pharmacists to dispense any lawfully prescribed drug or device without delay - AB626

Duty of pharmacists to dispense any lawfully prescribed drug or device without delay - SB705

Epinephrine auto-injector: cost sharing under health insurance policies and plans capped - AB1044

Epinephrine auto-injector: cost sharing under health insurance policies and plans capped - SB935

Epinephrine delivery systems: definition, authority to use, and prescribing authority - AB9

Epinephrine delivery systems: definition, authority to use, and prescribing authority [S.Amdt.1: premeasured epinephrine specified] - SB7

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified [Sec. 2631] - AB43

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified - AB848

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified [Sec. 2631] [original bill only] - SB70

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified - SB782

Federal drug pricing program (340B program): reimbursing certain entities and imposing a fee or other adjustment prohibited; OCI duties [Sec. 3091] - AB43

Federal drug pricing program (340B program): reimbursing certain entities and imposing a fee or other adjustment prohibited; OCI duties [Sec. 3091] [original bill only] - SB70

Health care cost revisions to prescription drugs under MA, insulin, pharmacy benefit managers fiduciary and disclosure requirements, certain 340B program entities drug repository program; diabetes medication pilot project; pharmacist continuing education credits; prescription drug importation program; pharmacy benefits tool grants; prescription drug purchasing entity study; pharmacy services administrative organization licensing; pharmaceutical representatives licensure; insulin safety net programs; JRCCP may report - AB748

Health care cost revisions to prescription drugs under MA, insulin, pharmacy benefit managers fiduciary and disclosure requirements, certain 340B program entities drug repository program; diabetes medication pilot project; pharmacist continuing education credits; prescription drug importation program; pharmacy benefits tool grants; prescription drug purchasing entity study; pharmacy services administrative organization licensing; pharmaceutical representatives licensure; insulin safety net programs; JRCCP may report - SB719

ID cards required to pick up certain prescribed controlled substances: adding certain ID cards and documents issued by a foreign government - AB445

ID cards required to pick up certain prescribed controlled substances: adding certain ID cards and documents issued by a foreign government - SB441

Insulin cost sharing cap set [Sec. 3096-3098, 9423 (3)] - AB43

Insulin cost sharing cap set [Sec. 3096-3098, 9423 (3)] [original bill only] - SB70

Insulin: cost sharing under health insurance policies and plans capped - AB584

Insulin: cost sharing under health insurance policies and plans capped - SB574

Insulin safety net programs created, reports required [Sec. 3090] - AB43

Insulin safety net programs created, reports required [Sec. 3090] [original bill only] - SB70

MA payment for puberty-blocking drugs or gender reassignment surgery prohibited [S.Sub.Amdt.2: Sec. 308-311] - SB70

Medical aid in dying provisions created; JRCCP may report - AB781

Medical aid in dying provisions created; JRCCP may report - SB739

Medical cannabis program created: Office of Medical Cannabis Regulation; licenses required; patient and caregiver registry; dispensaries, prescription drug monitoring program, child placement and custody, fair employment law, UI, WC, open housing law, sales tax exemption, and criminal penalty provisions; reports required - AB1040

Medicinal psilocybin treatment on patients with PTSD: pilot program at UW Madison established; trust fund and FDA provisions - AB753

Medicinal psilocybin treatment on patients with PTSD: pilot program at UW Madison established; trust fund and FDA provisions - SB727

Naloxone or other opioid antagonist: court can order criminal defendant to pay law enforcement agency’s costs for administration of - AB1058

Naloxone or other opioid antagonist: court can order criminal defendant to pay law enforcement agency’s costs for administration of - SB974

Opioid antagonist: funding to entities for purchase of [Sec. 802] - AB43

Opioid antagonist: funding to entities for purchase of [Sec. 802] [original bill only] - SB70

Opioid antagonist supply available in public schools and independent charter schools required [Sec. 2121, 2122] - AB43

Opioid antagonist supply available in public schools and independent charter schools required [A.Sub.Amdt.1: further revisions, provisions changed to civil liability exemption for administering an opioid antagonist re elementary and secondary schools] - AB223

Opioid antagonist supply available in public schools and independent charter schools required [Sec. 2121, 2122] [original bill only] - SB70

Opioid antagonist supply available in public schools and independent charter schools required - SB206

Pharmacy benefit managers: regulations, pharmaceutical product reimbursements, drug formularies, pharmacy networks, audits, fiduciary and disclosure requirements, prescription drug payments, discriminatory reimbursement of 340B entities, and reporting alleged violations revisions - AB773

Pharmacy benefit managers: regulations, pharmaceutical product reimbursements, drug formularies, pharmacy networks, audits, fiduciary and disclosure requirements, prescription drug payments, discriminatory reimbursement of 340B entities, and reporting alleged violations revisions - SB737

Prescription Drug Affordability Review Board created; Office of Prescription Drug Affordability created in OCI, FTE positions - AB747

Prescription Drug Affordability Review Board created; Office of Prescription Drug Affordability created in OCI, FTE positions - SB718

Prescription Drug Affordability Review Board created [Sec. 64, 76, 3042-3045, 9123 (1), 9423 (1)] - AB43

Prescription Drug Affordability Review Board created [Sec. 64, 76, 3042-3045, 9123 (1), 9423 (1)] [original bill only] - SB70

Prescription drug cost reporting by manufacturers: requirements established - AB1134

Prescription drug cost reporting by manufacturers: requirements established - SB1032

Prescription drug importation program established; JCF approval required [Sec. 3040, 9123 (2)] - AB43

Prescription drug importation program established; JCF approval required [Sec. 3040, 9123 (2)] [original bill only] - SB70

Pupils who have asthma: schools required to adopt a management plan which includes standing orders for short-acting bronchodilators; advanced practice nurse prescriber, physician assistant, and physician provisions and civil liability immunity - AB914

Pupils who have asthma: schools required to adopt a management plan which includes standing orders for short-acting bronchodilators; advanced practice nurse prescriber, physician assistant, and physician provisions and civil liability immunity - SB854

Ready-to-use glucagon rescue therapies: prescriptions and standing orders to public, private, and tribal schools from specified medical personnel; administration by school personnel; civil liability immunity - AB450

Ready-to-use glucagon rescue therapies: prescriptions and standing orders to public, private, and tribal schools from specified medical personnel; administration by school personnel; civil liability immunity [S.Amdt.1: changed to "undesignated glucogon," definitions revised] - SB447

SeniorCare participants allowed to purchase 100-day prescription drug supplies; rule revision and DHS to apply for federal Medicaid waiver [Admin.Code DHS 109.31] - AB259

SeniorCare participants allowed to purchase 100-day prescription drug supplies; rule revision and DHS to apply for federal Medicaid waiver [Admin.Code DHS 109.31] - SB263

Serious mental illness treatment: DHS prohibited from imposing utilization management controls for certain prescription drugs under the MA program - AB654

Serious mental illness treatment: DHS prohibited from imposing utilization management controls for certain prescription drugs under the MA program - SB618

State prescription drug purchasing entity study [Sec. 9123 (4)] - AB43

State prescription drug purchasing entity study [Sec. 9123 (4)] [original bill only] - SB70

Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring - AB836

Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring - SB807

Value-based diabetes medication pilot project [Sec. 3039] - AB43

Value-based diabetes medication pilot project [Sec. 3039] [original bill only] - SB70

Value-based purchasing arrangements under MA: DHS may enter into with a drug manufacturer - AB687

Value-based purchasing arrangements under MA: DHS may enter into with a drug manufacturer - SB672

Demolition of abated former drug dwellings: appropriation for reimbursements to DMA [Sec. 477] - AB43

Demolition of abated former drug dwellings: appropriation for reimbursements to DMA [Sec. 477] [original bill only] - SB70

First-degree reckless homicide re certain controlled substances: felony penalty changes; JRCCP may report - AB68

First-degree reckless homicide re certain controlled substances: felony penalty changes; JRCCP may report - SB101

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3334-3336] - AB43

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent - AB634

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3334-3336] [original bill only] - SB70

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent - SB595

Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised - AB1062

Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated - AB393

Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated - SB445

Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; excise tax and community reinvestment fund provisions; JRCCP may report; JSCTE appendix report; JLC study [Sec. 267, 268, 419, 523, 537, 598, 1023, 1128, 1156, 1157, 1174, 1180, 1544, 1602, 1730-1732, 1735, 1896, 1898, 1925, 1926, 1942, 2023, 2024, 2043, 2294, 2319, 2320, 2581, 2666, 2786, 3317, 3319-3323, 3325-3333, 3341, 3343-3349, 3355, 3356, 3362-3365, 3374, 9128 (1)] - AB43

Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; equity grants; excise tax; law enforcement training program; JRCCP may report; JSCTE appendix report - AB506

Marijuana legalization: recreational use amount limited; production, processing, and selling permit, medical marijuana registry; drug screening and testing; employment discrimination; excise tax and community reinvestment fund provisions; JRCCP may report; JSCTE appendix report; JLC study [Sec. 267, 268, 419, 523, 537, 598, 1023, 1128, 1156, 1157, 1174, 1180, 1544, 1602, 1730-1732, 1735, 1896, 1898, 1925, 1926, 1942, 2023, 2024, 2043, 2294, 2319, 2320, 2581, 2666, 2786, 3317, 3319-3323, 3325-3333, 3341, 3343-3349, 3355, 3356, 3362-3365, 3374, 9128 (1)] [original bill only] - SB70

Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; equity grants; excise tax; law enforcement training program; JRCCP may report; JSCTE appendix report - SB486

Marijuana possession or distribution: penalty for no more than 28 grams eliminated; distributing to a minor and ordinance provisions - AB1207

Marijuana possession or distribution: penalty for no more than 28 grams eliminated; distributing to a minor and ordinance provisions - SB1113

Marijuana possession penalties changed, local ordinance and drug paraphernalia provisions; employer liability for not drug testing employees or prospective employees; JRCCP may report - AB861

Medical cannabis program created: Office of Medical Cannabis Regulation; licenses required; patient and caregiver registry; dispensaries, prescription drug monitoring program, child placement and custody, fair employment law, UI, WC, open housing law, sales tax exemption, and criminal penalty provisions; reports required - AB1040

Pill tableting or pill encapsulation devices: possession, delivery, or manufacturing of prohibited; exceptions provided; JRCCP may report - AB1011

Pill tableting or pill encapsulation devices: possession, delivery, or manufacturing of prohibited; exceptions provided; JRCCP may report - SB931

Xylazine testing materials excluded from drug paraphernalia definition; civil and criminal liability exemption for distributing and administering testing products - AB950

Xylazine testing materials excluded from drug paraphernalia definition; civil and criminal liability exemption for distributing and administering testing products - SB875